Patents by Inventor Mark Bronstrup

Mark Bronstrup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydroxyphenylundecane, a process for their production and their use
    Publication number: 20040122092
    Abstract: The present invention relates to novel hydroxyphenylundecane derivatives of the formula (I), 1
    Type: Application
    Filed: October 1, 2003
    Publication date: June 24, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Cordula Hopmann, Martin Knauf, Mark Bronstrup, Astrid Markus-Erb, Luigi Toti
  • Caloporoside derivatives, methods of their preparation and use
    Publication number: 20020193316
    Abstract: The present invention relates to novel caloporoside derivatives and method of their use. The caloporoside derivatives may be formed by fermentation of microorganisms, such as Gloeoporus dichrous (Fr.: Fr.) Bres. ST001714 (DSM 13784). The invention also relates to use to a process for preparing caloporoside derivatives, drugs comprising such compounds, and methods of their use. The invention further relates to the microorganism Gloeoporus dichrous Bres. ST001714 (DSM 13784).
    Type: Application
    Filed: March 8, 2002
    Publication date: December 19, 2002
    Inventors: Claudia Eder, Michael Kurz, Mark Bronstrup, Luigi Toti
  • Citrullimycines, a process for their production and their use as pharmaceuticals
    Publication number: 20020065316
    Abstract: The present invention relates to novel active compounds named Citrullimycines, which are obtainable by cultivation of Streptomyces sp. ST 101396 (DSM 13309), and to their pharmaceutically acceptable salts and derivatives. The present invention further relates to a process for the production of the Citrullimycines, to the microorganism Streptomycetes sp. ST 101396 (DSM 13309), to the use of the Citrullimycines and their pharmaceutically acceptable salts and derivatives as pharmaceuticals, for example as inhibitors of the neurotensin receptor, and to pharmaceutical compositions comprising Citrullimycines or a pharmaceutically acceptable salt or derivative thereof.
    Type: Application
    Filed: October 1, 2001
    Publication date: May 30, 2002
    Inventors: Cordula Hopmann, Michael Kurz, Mark Bronstrup, Joachim Wink